These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 31619711)
1. CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure. Tsunekuni K; Konno M; Haraguchi N; Koseki J; Asai A; Matsuoka K; Kobunai T; Takechi T; Doki Y; Mori M; Ishii H Sci Rep; 2019 Oct; 9(1):14861. PubMed ID: 31619711 [TBL] [Abstract][Full Text] [Related]
2. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines. Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865 [TBL] [Abstract][Full Text] [Related]
3. CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype. Paschall AV; Yang D; Lu C; Redd PS; Choi JH; Heaton CM; Lee JR; Nayak-Kapoor A; Liu K Oncotarget; 2016 Nov; 7(48):78698-78712. PubMed ID: 27659530 [TBL] [Abstract][Full Text] [Related]
4. Identification of a subpopulation of long-term tumor-initiating cells in colon cancer. Peng L; Xiong Y; Wang R; Xiang L; Zhou H; Gu H Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32729895 [TBL] [Abstract][Full Text] [Related]
5. Pre-exposure to Fluorouracil Increased Trifluridine Incorporation and Enhanced its Anti-tumor Effect for Colorectal Cancer. Baba T; Kokuryo T; Yamaguchi J; Yokoyama Y; Uehara K; Ebata T; Nagino M Anticancer Res; 2018 Mar; 38(3):1427-1434. PubMed ID: 29491068 [TBL] [Abstract][Full Text] [Related]
6. Thymidine Kinase 1 Loss Confers Trifluridine Resistance without Affecting 5-Fluorouracil Metabolism and Cytotoxicity. Edahiro K; Iimori M; Kobunai T; Morikawa-Ichinose T; Miura D; Kataoka Y; Niimi S; Wakasa T; Saeki H; Oki E; Kitao H; Maehara Y Mol Cancer Res; 2018 Oct; 16(10):1483-1490. PubMed ID: 29866926 [TBL] [Abstract][Full Text] [Related]
7. Anti-EGFR antibody sensitizes colorectal cancer stem-like cells to Fluorouracil-induced apoptosis by affecting autophagy. Feng Y; Gao S; Gao Y; Wang X; Chen Z Oncotarget; 2016 Dec; 7(49):81402-81409. PubMed ID: 27833077 [TBL] [Abstract][Full Text] [Related]
8. Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2'-deoxy-5-fluorouridine into DNA. Sakamoto K; Yokogawa T; Ueno H; Oguchi K; Kazuno H; Ishida K; Tanaka N; Osada A; Yamada Y; Okabe H; Matsuo K Int J Oncol; 2015; 46(6):2327-34. PubMed ID: 25901475 [TBL] [Abstract][Full Text] [Related]
9. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA. Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858 [TBL] [Abstract][Full Text] [Related]
10. Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma. Gao X; Sheng Y; Yang J; Wang C; Zhang R; Zhu Y; Zhang Z; Zhang K; Yan S; Sun H; Wei J; Wang X; Yu X; Zhang Y; Luo Q; Zheng Y; Qiao P; Zhao Y; Dong Q; Qin L J Exp Clin Cancer Res; 2018 Jul; 37(1):179. PubMed ID: 30064482 [TBL] [Abstract][Full Text] [Related]
11. CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma. Shi C; Tian R; Wang M; Wang X; Jiang J; Zhang Z; Li X; He Z; Gong W; Qin R Cancer Biol Ther; 2010 Dec; 10(11):1182-90. PubMed ID: 20948317 [TBL] [Abstract][Full Text] [Related]
12. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers. Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682 [TBL] [Abstract][Full Text] [Related]
13. Cultivation and identification of colon cancer stem cell-derived spheres from the Colo205 cell line. Li YF; Xiao B; Tu SF; Wang YY; Zhang XL Braz J Med Biol Res; 2012 Mar; 45(3):197-204. PubMed ID: 22310487 [TBL] [Abstract][Full Text] [Related]
14. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer. Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024 [TBL] [Abstract][Full Text] [Related]
15. Detection of trifluridine in tumors of patients with metastatic colorectal cancer treated with trifluridine/tipiracil. Fujimoto Y; Nakanishi R; Nukatsuka M; Matsuoka K; Ando K; Wakasa T; Kitao H; Oki E; Maehara Y; Mori M Cancer Chemother Pharmacol; 2020 Jun; 85(6):1029-1038. PubMed ID: 32322913 [TBL] [Abstract][Full Text] [Related]
16. Effective Sequential Combined Chemotherapy with Trifluridine/Tipiracil and Regorafenib in Human Colorectal Cancer Cells. Matsuoka K; Nakagawa F; Tanaka N; Okabe H; Matsuo K; Takechi T Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30257515 [TBL] [Abstract][Full Text] [Related]
17. CD133-induced TM4SF5 expression promotes sphere growth via recruitment and blocking of protein tyrosine phosphatase receptor type F (PTPRF). Kim S; Cho CY; Lee D; Song DG; Kim HJ; Jung JW; Kim JE; Park D; Lee H; Um H; Park J; Choi Y; Kim Y; Nam SH; Lee JW Cancer Lett; 2018 Dec; 438():219-231. PubMed ID: 30217560 [TBL] [Abstract][Full Text] [Related]
18. Microenvironmentally-driven Plasticity of CD44 isoform expression determines Engraftment and Stem-like Phenotype in CRC cell lines. Dinger TF; Chen O; Dittfeld C; Hetze L; Hüther M; Wondrak M; Löck S; Eicheler W; Breier G; Kunz-Schughart LA Theranostics; 2020; 10(17):7599-7621. PubMed ID: 32685007 [TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of spheroid cells from the HT29 colon cancer cell line. Fan X; Ouyang N; Teng H; Yao H Int J Colorectal Dis; 2011 Oct; 26(10):1279-85. PubMed ID: 21670985 [TBL] [Abstract][Full Text] [Related]
20. MiR-139-5p reverses CD44+/CD133+-associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells. Xu K; Shen K; Liang X; Li Y; Nagao N; Li J; Liu J; Yin P Oncotarget; 2016 Nov; 7(46):75118-75129. PubMed ID: 27738333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]